- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05560256
Developing a Diabetes Mobile Health Application for and With Kenyan Adolescents
Building Capacity in Human-Centered Design: Developing a Diabetes Mobile Health Application for and With Kenyan Adolescents
Study Overview
Detailed Description
Aim #1 Train Kenyan health practitioners and software developers in HCD. We accomplished this by implementing an HCD curriculum during a three-day workshop with our Kenyan collaborators. Drs. Wyche, Olson and Holtz, travelled to Nairobi, Kenya, between September 28 and October 5 to conduct our three-day training workshop. Our collaborators from LakeHub (in Kisumu) also flew to Nairobi. Our other collaborators-from DMI-are based in Kenya's capital city. We held the workshop at the Ngong Hills Hotel in Nairobi.
Aim #2 Use HCD to build a prototype intervention for adolescents in Kenya with T1D. We accomplished this aim by conducting interviews; analyzing data; holding two design workshops; developing an initial version of a diary; conducting a pilot evaluation of the diary; and iterating upon the diary's design. Significant project outcomes include a personal diary.
In April 2022, Dr. Jennifer Olson, and our collaborators at DMI and ROA, interviewed 24 youth with T1D at two sites in Kenya (Vihiga County and Nairobi); 12 participants in each site. She also interviewed their parents/caregivers (n=22), as well as key stakeholders (e.g., doctors, teachers, community health workers). Interviews were digitally recorded (with participants' consent). During this time, we also provided youth with a digital camera and asked them to engage in a photovoice exercise (i.e., asking participants to take photographs, and then reflecting upon the reasons, emotions and experiences that motivated them to take the photos).
We hired translators-fluent in Kiswahili and English-to translate and transcribe the interviews. We also collected participants' photographs. Drs. Olson and Wyche analyzed this transcribed interviews and photographs in May-June 2022. Our objective was to deepen our understanding of how youth managed T1D and to identify possible technology interventions. A significant finding was that developing a mobile phone application would not support youths' existing practices. Most participants are not allowed to use mobile phones in school. Further, not all participants, especially those living in rural areas, had access to a smart phone.
In July 2022, Drs. Wyche and Olson travelled to Kenya. We held two, two-day design workshops (between July 3 and July 7). The first was held at Sosa Cottages (Majengo); the second was held at Ngong Hills Hotel (Nairobi). All of the youth and caregivers, who Dr. Olson interviewed in April, attended the workshops. Workshop objectives included: learning more about youth and T1D; and brainstorming design interventions that would help youth manage the disease. During these sessions, participants discussed their experiences managing T1D; they also talked about their photographs. Other significant activities include brainstorming exercises. Participants ideas included posters that would educate people about T1D, a calendar that would help youth keep track of their doctors' appointments, and diary that supported T1D-related activities. At the conclusion of the workshops Drs. Wyche and Olson determined that the diary was the most promising intervention. The diary would allow youth to track their sugar levels, as well as what they ate and their activity levels. The diary would also include useful information about how to effectively manage T1D (e.g., how to inject insulin, to make healthy meals, and properly store insulin). They worked with designed from LakeHub to develop an initial version of this diary.
In September 2022, the design team printed 60 initial copies of the diary. During this time, Drs. Wyche and Olson returned to Kenya to share these diaries with doctors, our collaborators (at DMI and ROA), and with the youth and their caregivers. Dr. Wyche met with Drs. Karakezi and Ngugi (DMI) to review the text in the diary. We also held two, daylong workshops-one in Vihiga and one in Nairobi-to introduce the diary to the youth and their parents. Our objective was to get preliminary feedback on how to improve the diary's design. Outcomes of these interviews and workshops included significant insights about changes that would improve the diary (e.g., modifying text, changing images, adding more information).
Aim #3 The final phase of the HCD process is implementation, or the project's formative evaluation phase. In September 2022, we gave the prototype diary to the youth, their caregivers, and other stakeholders who contributed to its development (e.g., doctors, and community health workers). Our objective was to validate the intervention's usefulness as well as the feasibility of using it to increase adolescents' knowledge of T1D and management of the disease. To achieve this goal, we conducted focus groups to assess youth's initial reactions to the diary, asked them to fill out pages (e.g., blood glucose monitoring page), and solicited feedback on the diary's strengths and weaknesses. We also administered a short survey to assess how often the diary was used during a one-month period. Participants' feedback was generally positive. They commented on the diary's professional appearance and noted the inclusion of images that were similar to their context (e.g., illustrations of foods they ate). We also received significant feedback on how to improve the diary. This included adding more information about how to properly store insulin-when you do not have access to a refrigerator-as well as guidance on how to best inject insulin. Survey data suggested frequent use of the diary (i.e., at least once a day).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nairobi, Kenya
- Nairobi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- T1D diagnosis 13-18 years old
- Have an A1c > 7
- Uses a phone
- Fluent in Swahili
Exclusion Criteria:
- Being treated for significant medical condition other than T1D
- Being treated for eating disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Youth Engage with Diary
24 youth will use the Diary for one month
|
Participants will be given a diary to record their blood glucose measurements, and other pertinent information (diet and activities).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Building Capacity in Human-Centered Design: Developing a Diabetes mHealth Application for and with Kenyan Adolescents
Time Frame: 1 month
|
Feasibility of Diary
|
1 month
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R21TW011339-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
GentiBio, IncRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes (T1D)United States
-
Stanford UniversityUniversity College Dublin; The Leona M. and Harry B. Helmsley Charitable TrustNot yet recruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM) | Exercise Physiology | Type 1 Diabetes MellitisUnited States
-
Dasman Diabetes InstituteRecruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM)Kuwait
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Insulet CorporationNot yet recruitingType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes (DM)New Zealand
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
Clinical Trials on Diary/Journal
-
Bambino Gesù Children's Hospital IRCCSMinistry of Health, ItalyRecruitingDepression | Anxiety | Post Traumatic Stress Disorder | Narrative Medicine | Post Intensive Care SyndromeItaly
-
Vanderbilt University Medical CenterVanderbilt UniversityEnrolling by invitationCritical IllnessUnited States
-
Tulane University School of MedicineThe Arnold P. Gold FoundationCompleted
-
University of SheffieldThe Leeds Teaching Hospitals NHS Trust; Sheffield Teaching Hospitals NHS Foundation... and other collaboratorsCompletedDepression | Wellbeing | Psychological Distress | Happiness | Emotional Distress | AffectUnited Kingdom
-
M.D. Anderson Cancer CenterCompleted
-
Milton S. Hershey Medical CenterFirst Affiliated Hospital of Heilongjiang Chinese Medicine UniversityCompleted
-
University of OttawaUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer... and other conditionsUnited States
-
University of British ColumbiaProvincial Health Services Authority; Vancouver Coastal Health; Canadian Initiative...Completed
-
University of Wisconsin, MadisonNot yet recruitingAdolescent Behavior | Social MediaUnited States